Literature DB >> 21327772

Oncology protocols: how can we do better?

Sue C Kaste1.   

Abstract

Diagnostic imaging provides information that is critical to the clinical care of pediatric oncology patients. Such information is also vital for assessing the effects of treatment on specific tumors during clinical trials. The design of such trials mandates standardization of imaging techniques, tumor measurements, data analysis, consistency of data collection and image interpretation in order to make scientific decisions about treatment regimens. In addition to these considerations, the optimal imaging modality to answer the scientific questions and simultaneously provide excellent patient care must be determined while minimizing patient exposure to ionizing radiation. This presentation will discuss these factors and potential means of improving upon inconsistencies, and consider factors that might influence the future.

Entities:  

Mesh:

Year:  2011        PMID: 21327772     DOI: 10.1007/s00247-011-1985-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  18 in total

1.  Introduction to session I: Helical CT and cancer risk.

Authors:  Eric J Hall
Journal:  Pediatr Radiol       Date:  2002-03-06

Review 2.  Pediatric cancer survivors: Past history and future challenges.

Authors:  Anna T Meadows
Journal:  Curr Probl Cancer       Date:  2003 May-Jun       Impact factor: 3.187

3.  Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.

Authors:  Parveen Bhatti; Lene H S Veiga; Cécile M Ronckers; Alice J Sigurdson; Marilyn Stovall; Susan A Smith; Rita Weathers; Wendy Leisenring; Ann C Mertens; Sue Hammond; Debra L Friedman; Joseph P Neglia; Anna T Meadows; Sarah S Donaldson; Charles A Sklar; Leslie L Robison; Peter D Inskip
Journal:  Radiat Res       Date:  2010-10-06       Impact factor: 2.841

4.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

Authors:  L A Mattano; H N Sather; M E Trigg; J B Nachman
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

5.  Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.

Authors:  D Gareth R Evans; R T Ramsden; A Shenton; C Gokhale; N L Bowers; S M Huson; G Pichert; A Wallace
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

6.  A mouse model for studying therapy-induced cancers.

Authors:  Anna T Meadows
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 7.  Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy.

Authors:  Alessandra Sala; Leonard A Mattano; Ronald D Barr
Journal:  Eur J Cancer       Date:  2006-12-13       Impact factor: 9.162

Review 8.  What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children's Oncology Group.

Authors:  Gregory H Reaman
Journal:  Pediatr Radiol       Date:  2008-12-16

Review 9.  Second cancers in survivors of childhood cancer.

Authors:  Smita Bhatia; Charles Sklar
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

10.  Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure.

Authors:  Hiromichi Kimura; Jessica M Y Ng; Tom Curran
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

View more
  1 in total

1.  The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma.

Authors:  Sara M Federico; Samuel L Brady; Alberto Pappo; Jianrong Wu; Shenghua Mao; Valerie J McPherson; Alison Young; Wayne L Furman; Robert Kaufman; Sue Kaste
Journal:  Pediatr Blood Cancer       Date:  2015-01-13       Impact factor: 3.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.